Sabater Juan R, Lee Troy A, Abraham William M
Division of Pulmonary and Critical Care Medicine, Miller School of Medicine, University of Miami at Mount Sinai Medical Center, FL 33140, USA.
Chest. 2005 Nov;128(5):3743-9. doi: 10.1378/chest.128.5.3743.
We measured tracheal mucus velocity (TMV), a marker of mucociliary clearance (MCC), in sheep before and for 12 h after treatment with salmeterol, albuterol, ipratropium, or vehicle to determine the effects on normal MCC. We also determined if these agents could reverse the depression in TMV caused by inhaled human neutrophil elastase (HNE), a model of abnormal MCC.
Study 1: TMV was measured initially and then for 6 h after metered-dose inhaler treatment with salmeterol (42 microg), albuterol (180 microg), ipratropium bromide (36 microg), or vehicle. After 6 h, the sheep in the albuterol and ipratropium treatment arms were administered a second dose of drug, whereas the salmeterol and vehicle treatment arms received vehicle. TMV was measured for another 6 h. Study 2: Six sheep inhaled HNE aerosol, which significantly reduced TMV by 2 h. At this point, the sheep were treated with either salmeterol, albuterol, ipratropium, or vehicle, and the effects on TMV were measured for another 6 h. This experiment was repeated in four sheep using only salmeterol and albuterol, but the posttreatment measurements were extended to 12 h.
Study 1: Only salmeterol and albuterol increased TMV (p < 0.05) during the initial 6-h period. From 6 to 12 h only, the salmeterol-treated sheep had TMV that remained at or above the initial TMV for the entire time, although both albuterol and ipratropium showed enhancement of TMV compared to vehicle. Study 2: Salmeterol and albuterol reversed the HNE-induced depression in TMV to a similar degree over the 6-h time course. However, the protection afforded by salmeterol was more prolonged than that seen with albuterol if the posttreatment interval was extended to 12 h. Ipratropium and vehicle had no effect.
We conclude that salmeterol and albuterol can stimulate normal MCC and reverse HNE-induced mucociliary dysfunction and that salmeterol has a longer duration of action in these models of normal and abnormal MCC.
我们测量了绵羊在使用沙美特罗、沙丁胺醇、异丙托溴铵或赋形剂治疗前及治疗后12小时的气管黏液速度(TMV),这是一种黏液纤毛清除功能(MCC)的标志物,以确定其对正常MCC的影响。我们还确定了这些药物是否能够逆转由吸入人中性粒细胞弹性蛋白酶(HNE)所导致的TMV降低,HNE是一种异常MCC的模型。
研究1:首先测量TMV,然后在用定量吸入器给予沙美特罗(42微克)、沙丁胺醇(180微克)、异丙托溴铵(36微克)或赋形剂治疗后6小时内进行测量。6小时后,沙丁胺醇和异丙托溴铵治疗组的绵羊给予第二剂药物,而沙美特罗和赋形剂治疗组给予赋形剂。再测量6小时的TMV。研究2:六只绵羊吸入HNE气雾剂,2小时后TMV显著降低。此时,给绵羊使用沙美特罗、沙丁胺醇、异丙托溴铵或赋形剂进行治疗,并在接下来的6小时内测量对TMV的影响。另外四只绵羊仅使用沙美特罗和沙丁胺醇重复该实验,但治疗后的测量时间延长至12小时。
研究1:在最初的6小时内,只有沙美特罗和沙丁胺醇能增加TMV(p<0.05)。仅在6至12小时期间,沙美特罗治疗的绵羊的TMV在整个时间段内保持在或高于初始TMV,尽管与赋形剂相比,沙丁胺醇和异丙托溴铵也显示出TMV的增加。研究2:在6小时的时间过程中,沙美特罗和沙丁胺醇在相似程度上逆转了HNE诱导的TMV降低。然而,如果将治疗后的间隔延长至12小时,沙美特罗提供的保护作用比沙丁胺醇更持久。异丙托溴铵和赋形剂没有效果。
我们得出结论,沙美特罗和沙丁胺醇可以刺激正常的MCC并逆转HNE诱导的黏液纤毛功能障碍,并且在这些正常和异常MCC模型中,沙美特罗具有更长的作用持续时间。